Study drug (Selumetinib) is first to help patients with recurrent low-grade ovarian cancer Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Friday, February 08, 2013

Study drug (Selumetinib) is first to help patients with recurrent low-grade ovarian cancer



Study drug is first to help patients with recurrent low-grade ovarian cancer

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.